Drug
Ulinastatin
Ulinastatin: highest development phase Post-Market, developed by Sun Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Sun Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| ulinastatin NCT01132521 | Post-Market | Pancreatitis |
Latest
No recent events.
Follow Ulinastatin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.